CENTRAL TRUST Co boosted its position in CVS Health Corp (NYSE:CVS) by 46.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 52,401 shares of the pharmacy operator’s stock after purchasing an additional 16,514 shares during the period. CENTRAL TRUST Co’s holdings in CVS Health were worth $3,434,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also recently made changes to their positions in CVS. Vanguard Group Inc. lifted its position in shares of CVS Health by 1.7% during the 3rd quarter. Vanguard Group Inc. now owns 84,873,814 shares of the pharmacy operator’s stock valued at $6,681,267,000 after acquiring an additional 1,445,887 shares during the period. Vanguard Group Inc lifted its position in shares of CVS Health by 1.7% during the 3rd quarter. Vanguard Group Inc now owns 84,873,814 shares of the pharmacy operator’s stock valued at $6,681,267,000 after acquiring an additional 1,445,887 shares during the period. BlackRock Inc. lifted its position in shares of CVS Health by 2.8% during the 3rd quarter. BlackRock Inc. now owns 76,197,017 shares of the pharmacy operator’s stock valued at $5,998,231,000 after acquiring an additional 2,061,915 shares during the period. FMR LLC lifted its position in shares of CVS Health by 4.3% during the 3rd quarter. FMR LLC now owns 30,069,260 shares of the pharmacy operator’s stock valued at $2,367,052,000 after acquiring an additional 1,250,473 shares during the period. Finally, Dodge & Cox acquired a new stake in shares of CVS Health during the 3rd quarter valued at approximately $1,190,694,000. Hedge funds and other institutional investors own 84.46% of the company’s stock.
CVS has been the subject of a number of research reports. Cantor Fitzgerald initiated coverage on shares of CVS Health in a research report on Sunday, December 2nd. They set an “overweight” rating and a $77.84 price target for the company. ValuEngine upgraded shares of CVS Health from a “sell” rating to a “hold” rating in a research report on Tuesday, November 6th. Bank of America reiterated a “buy” rating and set a $92.00 price target on shares of CVS Health in a research report on Thursday, January 3rd. Loop Capital set a $80.00 price target on shares of CVS Health and gave the company a “hold” rating in a research report on Friday, November 9th. Finally, Royal Bank of Canada set a $100.00 price target on shares of CVS Health and gave the company a “buy” rating in a research report on Wednesday, November 7th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. CVS Health currently has a consensus rating of “Buy” and a consensus price target of $91.98.
Shares of CVS opened at $68.53 on Wednesday. The company has a debt-to-equity ratio of 1.66, a current ratio of 2.44 and a quick ratio of 1.94. CVS Health Corp has a 1-year low of $60.14 and a 1-year high of $83.88. The company has a market cap of $68.08 billion, a PE ratio of 11.62, a price-to-earnings-growth ratio of 0.80 and a beta of 1.12.
CVS Health (NYSE:CVS) last issued its quarterly earnings data on Tuesday, November 6th. The pharmacy operator reported $1.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.71 by $0.02. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The business had revenue of $47.27 billion during the quarter, compared to analysts’ expectations of $47.22 billion. During the same period last year, the company posted $1.50 EPS. The company’s revenue was up 2.4% on a year-over-year basis. As a group, sell-side analysts expect that CVS Health Corp will post 7.04 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, February 4th. Shareholders of record on Friday, January 25th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Thursday, January 24th. This represents a $2.00 annualized dividend and a yield of 2.92%. CVS Health’s payout ratio is currently 33.90%.
In other CVS Health news, EVP Troyen A. Brennan sold 14,229 shares of CVS Health stock in a transaction that occurred on Wednesday, November 14th. The shares were sold at an average price of $82.00, for a total value of $1,166,778.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO David M. Denton sold 25,159 shares of CVS Health stock in a transaction that occurred on Thursday, November 29th. The stock was sold at an average price of $80.13, for a total transaction of $2,015,990.67. Following the completion of the sale, the chief financial officer now directly owns 403 shares of the company’s stock, valued at $32,292.39. The disclosure for this sale can be found here. 0.53% of the stock is currently owned by insiders.
WARNING: “CVS Health Corp (CVS) Position Raised by CENTRAL TRUST Co” was posted by Stock Observer and is the property of of Stock Observer. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://www.thestockobserver.com/2019/01/09/cvs-health-corp-cvs-position-raised-by-central-trust-co.html.
CVS Health Company Profile
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
See Also: Why is the conference call important?
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.